Cybin Reports Second Quarter Financial Results and Recent Business Highlights | Psychedelic Invest
–Announced unprecedented positive Phase 2 interim data for CYB003, its proprietary deuterated psilocybin analog, in major depressive disorder – – Announced closing of a unit